Navigation Links
Cancer Risk After Kidney Transplant Unaffected by Type of Drug Treatment
Date:4/29/2010

Risk similar from all drugs used to prevent organ rejection, researchers find

THURSDAY, April 29 (HealthDay News) -- The type of drug treatment used to prevent organ rejection in kidney transplant patients doesn't affect cancer risk, a new study finds.

Kidney transplant patients are at increased risk for cancer, likely because of patients' long-term use of immunosuppressive drugs to prevent organ rejection. In this study, Australian researchers examined the incidence of cancer in 481 kidney transplant patients.

The patients had received one of three treatment regimens: azathioprine and prednisolone; cyclosporine monotherapy; or cyclesoporine monotherapy followed by a switch to azathioprine and prednisolone after three months.

In the 20 years after transplant, 226 patients developed at least one cancer, including 48 percent who developed skin cancer and 27 percent who developed non-skin cancer. None of the anti-rejection treatments had a greater effect than another on cancer timing or incidence.

The findings indicate that "any differences in cancer risk from these different treatments are unlikely to be clinically significant," said study author Martin Gallagher, of the George Institute for International Health in Australia.

He and his colleagues also found that kidney transplant recipients' increased risk of cancer is significantly influenced by certain characteristics at the time of transplant. For example, non-skin cancer is associated with increasing age and previous smoking history, while skin cancer is associated with increasing age, non-brown eye color, fairer skin, and a functioning transplant.

High-risk patients need to be monitored more closely and use preventive measures to protect against cancer, the researchers said.

The study appears in the April 29 issue of the Journal of the American Society of Nephrology.

More information

The
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cells programmed to cure and even prevent cancer
2. FDA Approval of new Prostate Treatment Shows Promise of Cancer Immunotherapy
3. Prostate Cancer Vaccine Gains FDA Approval
4. CXCR4: A new drug target in lung cancer
5. Best care for the oldest lung cancer patients
6. Curcumin nanoparticles open up resistant cancers
7. Oncos Therapeutics raises €4 million ($5.3 million) to develop oncolytic viruses into cancer treatment
8. Breakthrough in Predicting Invasive Breast Cancer
9. Comparison of available breast cancer risk assessment tools shows room for improvement
10. Breakthrough method predicts risk of invasive breast cancer
11. Researchers attack stem cells that cause colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 2013, Paris, France: Routinely measuring fractional flow ... angiography for diagnosis of chest pain leads to ... four patients, according to results from a study ... routine pressure wire assessment influence management strategy at ... was designed to assess whether routine assessment of ...
(Date:5/24/2013)... Oregon Health & Science University highlights an ingenious method ... the highly evasive HIV virus that causes AIDS. The ... approach to develop its own HIV vaccine candidate, which ... This latest research finding will be published in the ... . , "A major challenge in developing an ...
(Date:5/24/2013)... 2013 CBT News.com recently announced the addition ... web-based retail automotive industry news organization with 12 years experience ... to join a group that’s so forward-thinking in their approach,” ... online video content is on the rise.” , Atlanta born ... and segued into advertising at Cycle News and Boating World. ...
(Date:5/24/2013)... American International College of Arts ... articulation agreement with Old Dominion University (ODU) ... Antigua. , The program will permit ODU ... a cell biology course, taught by AICASA’s faculty, for ... University of Antigua (AUA) College of Medicine , students ...
(Date:5/24/2013)... children who missed more than half of recommended well-child ... compared to children who attended most of their visits, ... American Journal of Managed Care . The study included ... , Children with chronic conditions like asthma and ... when they missed visits, according to the study. ...
Breaking Medicine News(10 mins):Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2Health News:AICASA Signs Articulation Agreement with Old Dominion University to Create Study Abroad Program 2Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3
... Wash., Sept. 15 Edifecs, the leader in ... has,selected the Edifecs Healthcare Accelerator Suite to automate ... and batch modes,within the product and development areas ... Sunny Singh, Edifecs, CEO said: "In response ...
... Misys Resolve Dispute, DALLAS, Sept. 15 iMedica ... dispute with Misys,Healthcare Systems LLC ("Misys")., Under the ... iMedica,PRM 2008 practice management (PM) and electronic health record ... its customers. The,agreement also states that iMedica will provide ...
... grant from the National Cancer Institute to find out ... tailored education in the user,s preferred language increases the ... The funding will be used to refine custom-designed software, ... evaluate its clinical impact in primary care physician,s offices ...
... Li, associate professor of biological sciences at Virginia ... cellular innate immunity network and human chronic inflammatory ... diseases. The finding presents a viable cellular and ... serious human inflammatory diseases, according to Li. ...
... advice , , MONDAY, Sept. 15 (HealthDay News) -- A ... about how they can preserve their ability to have ... , "It,s overwhelming for cancer patients to have ... same time that they are struggling to come to ...
... 15 Optical Cable,Corporation (Nasdaq: OCCF ), announced ... 2008 results today, September 15, 2008. The third,quarter results ... 2008. In conjunction with its release, the Company will ... 10:00 a.m. Eastern Time., Individuals wishing to participate ...
Cached Medicine News:Health News:Unisys Selects Edifecs Healthcare Accelerator Suite(TM) for MMIS System 2Health News:iMedica Announces Agreement with Misys 2Health News:UC Davis doctors use multimedia to increase colorectal cancer screening among Hispanics 2Health News:Key protein molecule linked to diverse human chronic inflammatory diseases 2Health News:Web Site Helps Cancer Patients With Fertility Preservation 2Health News:Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 2Health News:Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 3
(Date:5/23/2013)... Minn. , May 23, 2013  MGC Diagnostics ... a global medical technology company, today scheduled a conference ... quarter of fiscal year 2013, ended April 30, 2013. ... Thursday, May 30, 2013. The Company will report financial ... after the markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... More than half of women diagnosed with ... and still have excellent outcomes. To educate women, Agendia, ... largest sources of online consumer information about breast cancer ... provide recently diagnosed women with information sources, to help ... "We anticipate these innovative social media campaigns will ...
(Date:5/23/2013)... 2013  Texas, premier physician associations today announced the ... tools they need to provide demonstrably better and more ... marketplace. "I am confident the Physician Services ... Stephen L. Brotherton , MD, president ... doctors are determined to make health care ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
... a global leader in sourcing commercial drugs for clinical ... joined the company as Director, International Supply Services. He ... Matt brings to Myoderm 12 years experience working in ... companies. While at AstraZeneca, he was an R&D Sourcing ...
... 2012   CareFusion today announced its Alaris ... infusion system to receive a new data encryption certification ... of Veterans Affairs hospital networks. (Logo: ... Information Processing Standard (FIPS) 140-2, certifies that the ...
Cached Medicine Technology:CareFusion Receives Federal Data Encryption Certification for Alaris® Infusion System 2
... The RELISA ENA Multiparameter ... patient samples for six of ... kit features a unique quality ... (RELISA Procedure Check) well in ...
... Screening Kit is designed to screen patient samples ... microtiter well is coated with Sm, RNP, SS-A, ... laboratory to cost effectively screen out the ENA ... specificity on any of the company's other RELISA ...
... a host defense against foreign antigens and ... cleared, CIC may be deposited in tissue ... in Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis ... autoimmune disorders as well as in infectious ...
... Urine Controls are supplied as ... requiring no reconstitution or dilution. ... urine, fortified to target levels ... Preservatives including sodium azide have ...
Medicine Products: